Skip to content
Clinical Trials – home

curiositas ad sanum Studien und Beratungs GmbH

Verified siteinfo

Germany Krankenhausstrasse 4, 83527 Haag in Obb, Germany

  • Parkinson's disease · Atrial fibrillation · Haemorrhage intracranial
  • Adult patients

About Specializations

curiositas ad sanum Studien und Beratungs GmbH in Haag in Obb, Germany specialises in clinical trials of conditions such as Parkinson's disease, Atrial fibrillation, Haemorrhage intracranial, Migraine, and other specialisations. This site conducts important research.

Main research areas of the site

Neurology

The medical center is at the forefront of neurology research, with a particular focus on the treatment and prevention of chronic migraine. The institution is dedicated to advancing therapeutic options that improve the quality of life for patients suffering from debilitating neurological conditions.

  • Chronic Migraine Management
  • Neuropharmacology
  • Headache Disorders

Through rigorous clinical trials, the center evaluates innovative treatments such as Dysport®, aiming to reduce the frequency of migraine episodes and enhance patient outcomes.

Clinical Trials Concierge

Prefer not to search? Our Concierge searches the trials for you.

Site location
Krankenhausstrasse 483527 Haag in ObbGermany
Recruiting now
no trials
Conditions studied
4
Partner status
Verified site

More sites in Haag in ObbGermany

All trials

Ongoing trials

Clinical trials registered at this site – none is enrolling right now.

Condition
Type of trial
Recruitment status
Quick filters

4 clinical trials

Migraine

Not recruiting

Study on Lu AG09222 for Preventing Migraines in Adults Unresponsive to Previous Treatments

Investigational
Countries:GermanyGermany
  • Participants:18–64 years
  • Substances:Lu Ag09222
  • Sponsor:H. Lundbeck A/S

Parkinson's disease

Not recruiting

Study on the Long-Term Safety of Tavapadon for Patients with Parkinson's Disease

InvestigationalNo placebo
Countries:GermanyGermany
  • Participants:18–64 years · 65+ years
  • Substances:Tavapadon
  • Sponsor:Cerevel Therapeutics LLC

Atrial fibrillation+1

Not recruiting

Study on Edoxaban for Patients with Atrial Fibrillation and Previous Brain Bleeding

Registered drugNo placebo
Countries:GermanyGermany
  • Participants:18–64 years · 65+ years
  • Substances:Edoxaban
  • Sponsor:Hamilton Health Sciences Corporation

Parkinson's disease

Not recruiting

Study of Suvecaltamide for Treating Moderate to Severe Tremor in Parkinson's Disease Patients

Investigational
Countries:GermanyGermany
  • Participants:18–64 years · 65+ years
  • Substances:Suvecaltamide
  • Sponsor:Cavion Inc.
Is this your site?

Join our network of research sites

Move up to Verified & featured: your own description, photos and phone number on this page, and top placement on every trial you run.

See the offer for sites
Clinical Trials Concierge

Prefer not to search? Our Concierge searches the trials for you.

Tell us about your condition – we search every trial in Europe and connect you with the right site.